Sellas Life Sciences Group Inc.
SLS · Mid Cap · NASDAQ · Healthcare · Biotechnology
$11.50−$0.03 (-0.26%)
Market closed · opens in 13h 7mNext open: Monday, Sep 21, 9:30 AM ETFree AI brief
Get the full brief on SLS
Free to track. No card required. Usually ready in 10-15 minutes.
Where SLS sits today
Price, momentum, and the numbers behind the story.
52-week range
Low$1.39
High$15.88
Today $11.50
RSI (14)
41.6Neutral
03070100
Stocksbrew score
66/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
What Wall Street thinks
Where the analysts and the crowd stand, and what it's worth to know first.
Analyst price targets
Current price
$11.5
Lowest
$30
Median target
$32.5
Highest
$35
LowHigh
The business, by the numbers
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
RevenueTrend
✓ Good things about the company
Debt / equity
Favorable · 0.01 - strong leverage
0.01x
Current ratio
Strong · Good liquidity position
18.83x
⚠ Things to watch
ROIC
Weak · Weak capital efficiency
-25.1%
ROE
Needs attention · Unfavorable
-39.6%
How it stacks up against its peers
SLS against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $2.32B | - | - | 66 |
 | $9.95B | 18.9 | +19.7% | 78 |
 | $33.72B | 35.3 | +15.5% | 78 |
 | $4.12B | 12.4 | +13.5% | 78 |
 | $1.09T | 39.2 | +49.6% | 77 |
What is moving SLS
Every story that touched the stock this week, newest first.